A double-blinded, randomized controlled trial: comparison of the effectiveness of two single-dose vaginal tablets, Sertaconazole vs Clotrimazole, for treating vaginal candidiasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190308004

Enrollment

100

Registered

2019-03-08

Start date

2019-03-29

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Single dose Sertaconazole vaginal tablet,single dose Clotrimazole vaginal tablet

Experimental Drug,Experimental Drug

Sertaconazole,Clotrimazole

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: -Vaginal candidiasis

Exclusion criteria

Exclusion criteria: -Hypersensitivity to sertaconazole or clotrimazole

Design outcomes

Primary

Measure	Time frame
Cure rate of vaginal candidiasis 2 weeks Wet preparation	—

Secondary

Measure	Time frame
Side effect 2 weeks Questions	—

Countries

Thailand

Contacts

Public ContactChenchit Chayachinda

Faculty of Medicine Siriraj Hospital

chenchit.cha@mahidol.ac.th66863123623

Outcome results